Atlas Trials

Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW

Clinical trial NCT05359874 · WITHDRAWN

Trial details

NCT number
NCT05359874
Sponsor
Technical University of Munich
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-06-01
Primary completion
2023-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.